Publications:

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma.

Oncology Reports

Ye, Song S; Zhao, Xin-Yi XY; Hu, Xiao-Ge XG; Li, Tang T; Xu, Qiu-Ran QR; Yang, Huan-Ming HM; Huang, Dong-Sheng DS; Yang, Liu L

Publication Date: 2017-04

Variant appearance in text: TP53: R342a

PubMed Link: 28350084

Variant Present in the following documents:

• or-37-04-2215.pdf

View BVdb publication page

Characterization of the binding interaction between the oncoprotein gankyrin and a grafted S6 ATPase.

Biochemistry

Chapman, Alex M AM; Rogers, Bryce E BE; McNaughton, Brian R BR

Publication Date: 2014-11-11

Variant appearance in text: p53: R342A

PubMed Link: 25343477

Variant Present in the following documents:

• Main text
• bi5012354.pdf

View BVdb publication page